We are live on ! Find out more
JANX icon

Janux Therapeutics
JANX

44 hedge funds and large institutions have $318M invested in Janux Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.24% more ownership

Funds ownership: 68.21% → 69.45% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 15

6% less funds holding

Funds holding: 47 → 44 (-3)

22% less capital invested

Capital invested by funds: $407M → $318M (-$88.7M)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
44
Holders Change
-3
Holders Change %
-6.38%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
15
Reduced
15
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
BVF Inc
California
+$3.88M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.76M
3
JP Morgan Chase
JP Morgan Chase
New York
+$1.01M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$990K
5
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
+$586K

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$2.5M
2
SB
Samsara BioCapital
California
-$609K
3
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$254K
4
Bank of America
Bank of America
North Carolina
-$185K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$165K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$292K +$91K +7,686 +47%
Goldman Sachs
27
Goldman Sachs
New York
$194K -$24.5K -2,070 -12%
MIM
28
MetLife Investment Management
New Jersey
$130K – – –
Deutsche Bank
29
Deutsche Bank
Germany
$113K -$16.1K -1,356 -13%
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$98K -$88.9K -7,508 -48%
AIG
31
American International Group
New York
$98K -$9.25K -781 -9%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$90K -$2.85K -241 -3%
O
33
OrbiMed
New York
$34.6K – – –
AB
34
Amalgamated Bank
New York
$27K +$3.01K +254 +13%
Citigroup
35
Citigroup
New York
$26K +$3.56K +301 +16%
TRCT
36
Tower Research Capital (TRC)
New York
$24K +$8.55K +722 +58%
Legal & General Group
37
Legal & General Group
United Kingdom
$18K -$3.08K -260 -15%
MLICM
38
Metropolitan Life Insurance Company (MetLife)
New York
$16.9K – – –
AIP
39
Ameritas Investment Partners
Nebraska
$12K – – –
Barclays
40
Barclays
United Kingdom
$11K -$24.7K -2,088 -71%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$1K -$11.8K -995 -91%
Daiwa Securities Group
42
Daiwa Securities Group
Japan
$1K – – –
CA
43
Crewe Advisors
Utah
$1K +$1.36K +115 New
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
– -$254K -17,700 Closed
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
– -$165K -11,480 Closed
Allspring Global Investments
46
Allspring Global Investments
North Carolina
– -$68K -4,742 Closed
UBS Group
47
UBS Group
Switzerland
– -$50K -3,500 Closed
Kayne Anderson Rudnick Investment Management
48
Kayne Anderson Rudnick Investment Management
California
– -$1K -42 Closed
CS
49
Credit Suisse
Switzerland
– +$201 +17 New
1
2

JANX Hedge Fund Activity: Q2 2022 in Review

44 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Janux Therapeutics (JANX) for Q2 2022, worth a combined $318M — down 22% from $407M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of JANX and 3 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 15 added.

The largest buyer was BVF Inc, adding an estimated $3.88M. The largest seller was Janus Henderson Group, cutting an estimated $2.5M.

  • 44 institutional investors held Janux Therapeutics (JANX) as of Q2 2022, down from 47 in Q1 2022.
  • Funds reported $318M of Janux Therapeutics stock for Q2 2022, down 22% quarter-over-quarter.
  • 3 funds opened new Janux Therapeutics positions in Q2 2022 and 5 closed out, a net change of -2 holders.
  • The largest Janux Therapeutics buyer in Q2 2022 was BVF Inc, an estimated $3.88M added.
  • The largest Janux Therapeutics seller in Q2 2022 was Janus Henderson Group, an estimated $2.5M sold.

Based on aggregated 13F filings for Q2 2022.